Mauli Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 Cr
- Revenue Growth 4554.61%
- Profit Growth 232.13%
- Ebitda 6916.75%
- Net Worth 144.56%
- Total Assets 54.39%
About Mauli Medical Sciences
Mauli Medical Sciences Private Limited (MMSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2020 (Four years and three months 7 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 Cr.
Atulram Agrawal and Vipul Palan serve as directors at the Company.
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300MH2020PTC350423
- Company No.
350423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mauli Medical Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atulram Agrawal  | Director | 20-Nov-2020 | Current |
| Vipul Palan | Director | 20-Nov-2020 | Current |
Financial Performance of Mauli Medical Sciences.
Mauli Medical Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4554.61% increase. The company also saw a substantial improvement in profitability, with a 232.13% increase in profit. The company's net worth Soared by an impressive increase of 144.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mauli Medical Sciences?
In 2022, Mauli Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elish Infratech LlpVipul Palan is a mutual person
- Ashtalaxmi Infrastructures Private Limited
Vipul Palan is a mutual person
Charges (Loans)
₹60.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 6.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2020 | Others | ₹6.00 Cr | Open |
How Many Employees Work at Mauli Medical Sciences?
Mauli Medical Sciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mauli Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mauli Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.